<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699645</url>
  </required_header>
  <id_info>
    <org_study_id>TRIDENT-1103886</org_study_id>
    <nct_id>NCT02699645</nct_id>
  </id_info>
  <brief_title>Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial</brief_title>
  <acronym>TRIDENT</acronym>
  <official_title>Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The George Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of New South Wales</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The George Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      An investigator initiated and conducted, multicentre, international, double-blinded,&#xD;
      placebo-controlled, parallel-group, randomised controlled trial to determine the effect of&#xD;
      more intensive blood pressure control provided by a fixed low-dose combination blood pressure&#xD;
      lowering pill (&quot;Triple Pill&quot;) strategy on top of standard of care, on time to first&#xD;
      occurrence of recurrent stroke in patients with a history of stroke due to intracerebral&#xD;
      haemorrhage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intracerebral haemorrhage (ICH) is the most serious and least treatable form of stroke,&#xD;
      accounting for at least 10% of the 20 million new strokes that occur globally each year.&#xD;
      Survivors of ICH are at high risk of recurrent ICH and other serious cardiovascular events.&#xD;
&#xD;
      While there is strong evidence that this risk can be reduced by lowering the blood pressure&#xD;
      (BP) of patients after ICH, many patients with ICH do not receive BP-lowering treatment&#xD;
      long-term unless BP levels are particularly high, and many do not receive BP combination&#xD;
      therapy.&#xD;
&#xD;
      The aim of this study is to assess the safety and efficacy of a combination of fixed low-dose&#xD;
      generic BP lowering agents, as a &quot;Triple Pill&quot; strategy on top of standard of care for the&#xD;
      prevention of recurrent stroke in patients with a history of ICH and high normal or low grade&#xD;
      hypertension. The study is a large-scale, international, double-blind, placebo-controlled,&#xD;
      randomised controlled trial.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 28, 2017</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrent Stroke</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Time to first occurrence of recurrent stroke, whether ischaemic or haemorrhagic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrent ICH</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Time to first occurrence of recurrent ICH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischaemic Stroke</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Time to first occurrence of ischaemic stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal or disabling stroke</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Time to first occurrence of fatal or disabling stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Major adverse cardiovascular events - CV death, non-fatal MI or non-fatal stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Physical function as assessed by smRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SBP</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Change in SBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HRQoL according to the EQ-5D-3L</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Health-related quality of life according to the European Quality of Life 5-Dimensional Assessment, 3-Level version</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Impairment</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Overall defined by standard cut-points on the Montreal Cognitive Assessment (MoCA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Impairment Supplement</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Overall defined by standard cut-points with Brief Memory and Executive Test (BMET)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>Average of 6 years</time_frame>
    <description>Self-reported measures, Pill counts</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Intracerebral Haemorrhage (ICH)</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Triple Pill (active treatment)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>received via blinded study capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg</intervention_name>
    <description>1 capsule taken orally once daily for average of 72 months</description>
    <arm_group_label>Triple Pill (active treatment)</arm_group_label>
    <other_name>Triple Pill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 capsule taken orally once daily for average of 72 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (â‰¥18 years) with a history of up to 12 months after symptom onset of primary&#xD;
             ICH that is confirmed by imaging (copy of the brain imaging report to be uploaded to&#xD;
             the database, labelled with participant identification (ID) and with personal&#xD;
             identifiers removed)&#xD;
&#xD;
          -  Clinically stable, as judged by investigator&#xD;
&#xD;
          -  Average of two resting SBP levels measured 5 minutes apart in the range 130-160mmHg&#xD;
             recorded in a seated position (National Heart Foundation of Australia Guidelines).&#xD;
             (Patients with higher SBP can be included if considered by attending clinician that&#xD;
             management is consistent with local standards of clinical practice)&#xD;
&#xD;
          -  Geographical proximity to the recruiting hospital and/or follow-up medical clinic site&#xD;
             to allow ready access for in-person clinic visits during follow-up&#xD;
&#xD;
          -  No clear contraindication to any of the study treatments&#xD;
&#xD;
          -  Provision of written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Taking an ACE-I that cannot be switched to any of the following alternatives:&#xD;
&#xD;
               -  telmisartan 20 or 40mg, amlodipine 2.5 or 5mg, indapamide 1.25mg, or&#xD;
&#xD;
               -  an equivalent class (ARB, CCB or thiazide [TZ]-like diuretic), or&#xD;
&#xD;
               -  a BB&#xD;
&#xD;
          -  Contraindication to any of the study medications, in the context of currently&#xD;
             prescribed BP-lowering medication&#xD;
&#xD;
          -  Unable to complete the study procedures and/or follow-up&#xD;
&#xD;
          -  Females of child-bearing age and capability, who are pregnant or breast-feeding, or&#xD;
             those of child-bearing age and capability who are not using adequate birth control&#xD;
&#xD;
          -  Significant hyperkalaemia and/or hyponatremia, in the opinion of the responsible&#xD;
             physician&#xD;
&#xD;
          -  Estimated glomerular filtration rate (eGFR) &lt;30mL/min/1.73m2&#xD;
&#xD;
          -  Severe hepatic impairment (alanine aminotransferase [ALT] or aspartate&#xD;
             aminotransferase [AST] &gt;3x the upper limit of normal [ULN])&#xD;
&#xD;
          -  Any other condition that in the opinion of the responsible physician investigator&#xD;
             renders the patient unsuitable for the study (e.g. severe disability [i.e. simplified&#xD;
             modified Rankin Scale (smRS) of 4-5] or significant memory or behavioural disorder)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig Anderson</last_name>
    <role>Principal Investigator</role>
    <affiliation>The George Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Grace Balicki</last_name>
    <phone>+61 2 8052 4811</phone>
    <email>gbalicki@georgeinstitute.org.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruth Freed</last_name>
    <phone>+61 2 8052 4522</phone>
    <email>rfreed@georgeinstitute.org.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Calvary Public Hospital</name>
      <address>
        <city>Bruce</city>
        <state>Australian Capital Territory</state>
        <zip>2617</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Port Macquarie Base Hospital</name>
      <address>
        <city>Port Macquarie</city>
        <state>New South Wales</state>
        <zip>2444</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>Saint Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Sunshine Coast University Hospital</name>
      <address>
        <city>Birtinya</city>
        <state>Queensland</state>
        <zip>4575</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Queensland Centre for Clinical Research</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital das ClÃ­nicas de Botucatu</name>
      <address>
        <city>Botucatu</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernanda Winckler</last_name>
      <email>fernanda_winckler@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Rodrigo Bazan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Celso Ramos</name>
      <address>
        <city>FlorianÃ³polis</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica NeurolÃ³gica e Neurocirurgica de Joinville</name>
      <address>
        <city>Joinville</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Paula de Oliveira Pires</last_name>
      <email>centrodepesquisaavc@neurologica.com.br</email>
    </contact>
    <investigator>
      <last_name>Carla Heloisa Cabral Moro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital das ClÃ­nicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natacha Fleck</last_name>
      <email>pesquisaneurovascular@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Shiela Cristina Ouriques Martins</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Moinhos de Vento</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana De Souza</last_name>
      <email>neuroana87@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Shiela Cristina Ouriques Martins</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital das ClÃ­nicas de RibeirÃ£o Preto</name>
      <address>
        <city>RibeirÃ£o Preto</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henrique Afonso S. Pereira</last_name>
      <email>haspereira@hcrp.usp.br</email>
    </contact>
    <investigator>
      <last_name>Octavio Marques Pontes Neto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Base SÃ£o JosÃ© do Rio Preto</name>
      <address>
        <city>Rio PrÃªto</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thiago Souza</last_name>
      <email>thiagosouza.cip@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Salvador (HBA)</name>
      <address>
        <city>Salvador</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Universidade Federal de SÃ£o Paulo</name>
      <address>
        <city>SÃ£o Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ilana Izidoro da Silva</last_name>
      <email>ilana.silva@fapunifesp.edu.br</email>
    </contact>
    <investigator>
      <last_name>Gisele Sampiao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LTD Pineo Medical Ecosystem</name>
      <address>
        <city>Tbilisi</city>
        <zip>0112</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The First University Clinic of Tbilisi State Medical University</name>
      <address>
        <city>Tbilisi</city>
        <zip>0141</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>LTD Urgent Neurological Clinic &quot;Neurology&quot;</name>
      <address>
        <city>Tbilisi</city>
        <zip>0144</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tinatin Kherkheulidze</last_name>
      <email>tinatinkherkheulidze@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Nodar Kakabadze</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LTD S. Khechinashvili University Hospital</name>
      <address>
        <city>Tbilisi</city>
        <zip>0179</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <zip>6815 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zuyderland Medical Centre</name>
      <address>
        <city>Heerlen</city>
        <zip>6419 PC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Radboud University Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525 GC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Medical Centre, Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University College Hospital Ibadan</name>
      <address>
        <city>Ibadan</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Ilorin</name>
      <address>
        <city>Ilorin</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jos University Teaching Hospital</name>
      <address>
        <city>Jos</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lagos University Teaching Hospital, Lagos</name>
      <address>
        <city>Lagos</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ahmadu Bello University Teaching Hospital</name>
      <address>
        <city>Zaria</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Colombo North Teaching Hospital</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Udaya Ranawake</last_name>
    </contact>
    <investigator>
      <last_name>Udaya Ranawake</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kalubowila (Colombo South) Teaching Hospital</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arjuna Fernando</last_name>
    </contact>
    <investigator>
      <last_name>Arjuna Fernando</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Hospital of Sri Lanka</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bimsara Senanayake</last_name>
    </contact>
    <investigator>
      <last_name>Bimsara Senanayake</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karapitiya Teaching Hospital</name>
      <address>
        <city>Galle</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charika Rajinee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gampaha District General Hospital</name>
      <address>
        <city>Gampaha</city>
        <zip>11000</zip>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kanchana Karunathilake</last_name>
      <email>kanchana.maduwanthi@remediumone.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jaffna Teaching Hospital</name>
      <address>
        <city>Jaffna</city>
        <zip>40000</zip>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Priyanth</last_name>
      <email>johnpriyanth@remediumone.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kandy Teaching Hospital</name>
      <address>
        <city>Kandy</city>
        <zip>20000</zip>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Shafras</last_name>
    </contact>
    <investigator>
      <last_name>Indunil Wijeweera, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Teaching Hospital Kurunegala</name>
      <address>
        <city>Kurunegala</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janaka Peiris</last_name>
    </contact>
    <investigator>
      <last_name>Janaka Peiris</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sri Jayewardenepura General Hospital</name>
      <address>
        <city>Nugegoda</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harsha Gunasekara</last_name>
    </contact>
    <investigator>
      <last_name>Harsha Gunasekara</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peradeniya Teaching Hospital</name>
      <address>
        <city>Peradeniya</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadie Ratnayake</last_name>
    </contact>
    <investigator>
      <last_name>Nadie Ratnayake</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ragama Teaching Hospital</name>
      <address>
        <city>Ragama</city>
        <zip>11010</zip>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonali Liyanagamage</last_name>
    </contact>
    <investigator>
      <last_name>Sharshana Wijegunasinghe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of Zurich</name>
      <address>
        <city>ZÃ¼rich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Chiayi Chang Gung Memorial Hospital</name>
      <address>
        <city>Chiayi City</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>833</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Keelung Chang Gung Memorial Hospital</name>
      <address>
        <city>Keelung</city>
        <zip>204</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Linkou Chang Gung Memorial Hospital</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>West Suffolk Hospital</name>
      <address>
        <city>Bury Saint Edmunds</city>
        <zip>IP33 2QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Countess of Chester</name>
      <address>
        <city>Chester</city>
        <zip>CH2 1UL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Devon &amp; Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth University Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Halifax Royal Infirmary Calderdale Hospital</name>
      <address>
        <city>Halifax</city>
        <zip>HX3 0PW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Victoria Hospital</name>
      <address>
        <city>Kirkcaldy</city>
        <zip>KY2 5AH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital</name>
      <address>
        <city>Nottingham</city>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Salford Royal Hospital</name>
      <address>
        <city>Salford</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Hallamshire Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S10 2JF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Stoke University Hospital</name>
      <address>
        <city>Stoke-on-Trent</city>
        <zip>T4 6QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Georgia</country>
    <country>Netherlands</country>
    <country>Nigeria</country>
    <country>Singapore</country>
    <country>Sri Lanka</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>August 25, 2021</last_update_submitted>
  <last_update_submitted_qc>August 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood Pressure (BP)</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amlodipine</mesh_term>
    <mesh_term>Telmisartan</mesh_term>
    <mesh_term>Indapamide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>2 years after publication of main results</ipd_time_frame>
    <ipd_access_criteria>Bone fide researchers submit protocol to the Research Office of The George Institute for Global Health</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

